tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Biovica International AB Class B (DE:9II)
:9II
Germany Market
9II
Biovica International AB Class B
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Biovica International AB Class B (9II) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

9II Financial Forecast

9II Earnings Forecast

Next quarter’s earnings estimate for 9II is >-€0.01 with a range of >-€0.01 to >-€0.01. The previous quarter’s EPS was -€0.02. 9II beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.18% of the time in the same period. In the last calendar year 9II has Outperformed its overall industry.
Next quarter’s earnings estimate for 9II is >-€0.01 with a range of >-€0.01 to >-€0.01. The previous quarter’s EPS was -€0.02. 9II beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.18% of the time in the same period. In the last calendar year 9II has Outperformed its overall industry.

9II Sales Forecast

Next quarter’s sales forecast for 9II is €237.19K with a range of €237.19K to €237.19K. The previous quarter’s sales results were €206.62K. 9II beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.50% of the time in the same period. In the last calendar year 9II has Preformed in-line its overall industry.
Next quarter’s sales forecast for 9II is €237.19K with a range of €237.19K to €237.19K. The previous quarter’s sales results were €206.62K. 9II beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.50% of the time in the same period. In the last calendar year 9II has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
AI Firm Analyst forecast on DE:9II
Dex GenotekAI Firm
AI Firm
€0.09
Hold
123.84%
Upside
Upgraded
05/22/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
AI Firm Analyst forecast on DE:9II
Dex GenotekAI Firm
AI Firm
€0.09
Hold
123.84%
Upside
Upgraded
05/22/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

9II Analyst Recommendation Trends

Rating
May 25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
In the current month, 9II has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 9II average Analyst price target in the past 3 months is 0.09.
Each month's total comprises the sum of three months' worth of ratings.

9II Stock Forecast FAQ

What is DE:9II’s average 12-month price target, according to analysts?
Based on analyst ratings, Biovica International AB Class B’s 12-month average price target is 0.09.
    What is DE:9II’s upside potential, based on the analysts’ average price target?
    Biovica International AB Class B has 125.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Biovica International AB Class B a Buy, Sell or Hold?
          Biovica International AB Class B has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Biovica International AB Class B’s share price target?
            The average share price target for Biovica International AB Class B is 0.09. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €0.09 ,and the lowest forecast is €0.09. The average share price target represents 125.00% Increase from the current price of <€0.1.
              What do analysts say about Biovica International AB Class B?
              Biovica International AB Class B’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Biovica International AB Class B?
                To buy shares of DE:9II, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

                  Become an Expert with TipRanks Premium

                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis
                  Subscribe NowSee Plans & Pricing